Efrossini Briassouli1, Dimitris Goukos1, George Daikos1, Kleovoulos Apostolou2, Christina Routsi2, Serafim Nanas2, George Briassoulis3. 1. First Department of Internal Medicine, Medical School, University of Athens, Laikon Hospital, Athens, Greece. 2. First Department of Critical Care, Medical School, University of Athens, Evangelismos Hospital, Athens, Greece. 3. Pediatric Intensive Care Unit, University Hospital, University of Crete, Heraklion, Greece. Electronic address: Ggbriass@otenet.gr.
Abstract
OBJECTIVE: L-Alanyl-glutamine (L-Ala-Gln) is a pharmaco-nutrient commonly used in nutrition regimens due to its immunomodulatory effects. In critically ill patients who are septic, L-Ala-Gln was associated with an increase in mortality. The aim of this study was to investigate whether L-Ala-Gln modulated heat shock protein (Hsp)-72, 90-α, T helper (Th)1, Th2, and Th17 cytokine expression in the peripheral blood mononuclear cells (PBMC) of patients with severe sepsis. METHODS: Time-dose effects of L-Ala-Gln were compared with those of L-glutamine (L-Gln) and lipopolysaccharide (LPS) and to healthy controls. PBMCs were incubated with 1 or 10 μg/mL LPS, 5 or 10 mM L-Gln, and 5 or 10 mM L-Ala-Gln for different periods of time (0; 4; 24 h) when culture supernatants were harvested. RESULTS: In both groups, basal Hsp72 increased over time (P < 0.02); Hsp90-α levels declined in controls (P < 0.02) but remained increased in septic patients (P < 0.02), not exhibiting any significant time-response trend. Both Glns suppressed Hsp72 in septic and controls at 10 mM by 4 h (P < 0.045) and Hsp90-α in the control group by 24 h (P < 0.045). LPS did not induce Hsps in either group. L-Ala-Gln did not induce any of the Th1, Th2, and Th17 cytokines in either group. CONCLUSION: High doses of L-Gln or L-Ala-Gln do not induce any of the Th1, Th2, and Th17 cytokines in either healthy or septic human PBMCs. High Gln doses suppress Hsp72 in septic and control PBMCs. Hsp90-α time-series expression declines, contrasting the increasing trend of Hsp72 in healthy controls. Hsp90-α sustains increased levels in septic supernatants, showing a characteristic longitudinal behavior needed further elucidation.
OBJECTIVE:L-Alanyl-glutamine (L-Ala-Gln) is a pharmaco-nutrient commonly used in nutrition regimens due to its immunomodulatory effects. In critically illpatients who are septic, L-Ala-Gln was associated with an increase in mortality. The aim of this study was to investigate whether L-Ala-Gln modulated heat shock protein (Hsp)-72, 90-α, T helper (Th)1, Th2, and Th17 cytokine expression in the peripheral blood mononuclear cells (PBMC) of patients with severe sepsis. METHODS: Time-dose effects of L-Ala-Gln were compared with those of L-glutamine (L-Gln) and lipopolysaccharide (LPS) and to healthy controls. PBMCs were incubated with 1 or 10 μg/mL LPS, 5 or 10 mM L-Gln, and 5 or 10 mM L-Ala-Gln for different periods of time (0; 4; 24 h) when culture supernatants were harvested. RESULTS: In both groups, basal Hsp72 increased over time (P < 0.02); Hsp90-α levels declined in controls (P < 0.02) but remained increased in septic patients (P < 0.02), not exhibiting any significant time-response trend. Both Glns suppressed Hsp72 in septic and controls at 10 mM by 4 h (P < 0.045) and Hsp90-α in the control group by 24 h (P < 0.045). LPS did not induce Hsps in either group. L-Ala-Gln did not induce any of the Th1, Th2, and Th17 cytokines in either group. CONCLUSION: High doses of L-Gln or L-Ala-Gln do not induce any of the Th1, Th2, and Th17 cytokines in either healthy or septic human PBMCs. High Gln doses suppress Hsp72 in septic and control PBMCs. Hsp90-α time-series expression declines, contrasting the increasing trend of Hsp72 in healthy controls. Hsp90-α sustains increased levels in septic supernatants, showing a characteristic longitudinal behavior needed further elucidation.
Authors: Steven G Griffiths; Alan Ezrin; Emily Jackson; Lisa Dewey; Alan A Doucette Journal: Cell Stress Chaperones Date: 2019-10-24 Impact factor: 3.667
Authors: Anderson Vulczak; Carlos Henrique Rocha Catalão; Luiz Alexandre Pedro de Freitas; Maria José Alves Rocha Journal: Int J Mol Sci Date: 2019-08-30 Impact factor: 5.923
Authors: K Vardas; K Apostolou; E Briassouli; D Goukos; K Psarra; E Botoula; S Tsagarakis; E Magira; C Routsi; S Nanas; G Briassoulis Journal: Biomed Res Int Date: 2014-08-27 Impact factor: 3.411
Authors: Efrossini Briassouli; Marianna Tzanoudaki; Dimitris Goukos; Christina Routsi; Serafim Nanas; Kostas Vardas; Kleovoulos Apostolou; Maria Kanariou; George Daikos; George Briassoulis Journal: Biomed Res Int Date: 2015-10-13 Impact factor: 3.411
Authors: Frank Kaiser; Nikos Donos; Brian Henderson; Rajesh Alagarswamy; George Pelekos; David Boniface; Luigi Nibali Journal: Cell Stress Chaperones Date: 2018-05-15 Impact factor: 3.667